Alzheimer’s disease and related dementias (ADRD) affect 47 million people worldwide—a number expected to double every 20 years. Yet, research lacks diversity, especially for underrepresented populations, creating gaps in understanding how different communities experience ADRD and respond to treatments.
The core set of digital measures of ADRD provide you with metrics that connect technology to the real experiences of patients and their care partners based on DATAcc’s survey of the global ADRD community. Use these resources to enhance your trial process, ensure consistent data across studies, support diverse recruitment, and enable real-time insights for earlier, data-driven decisions.
Partners
Also funded by 
Digital solution collaborators
In the news
New tools for Parkinson’s added to Digital Medicine Society library
No Moonshots With Paper Planes: Alzheimer’s Trials Need Neurotech
Advancing Digital Approaches in Alzheimer’s Research and Care ft. Sarah Averill Lott, DiMe and Diane Stephenson, Critical Path for Parkinson
Digital Health Technologies for Alzheimer’s Disease and Related Dementias: Initial Results from a Landscape Analysis and Community Collaborative Effort
